Loading... Please wait...

Our Newsletter



The benefit of breast thermography is that it offers the opportunity of earlier
detection of breast disease than has been possible through breast self examination, doctor examination or mammography alone.
Thermography can detect the subtle physiologic changes that accompany breast
pathology, whether it is cancer, fibrocystic disease, an infection or a vascular
disease. Your doctor can then plan accordingly and lay out a careful program to
further diagnose and / or MONITOR you during and after any treatment.
Thermography's role in breast cancer and other breast disorders is to help in early
detection and monitoring of abnormal physiology and the establishment of risk
factors for the development or existance of cancer. When used with other procedures.
What is DITI?
Digital Infrared Thermal Imaging "DITI" is a 15 minute non invasive test of physiology. It is a valuable procedure for alerting your doctor to changes that can indicate early stage breast disease. The benfit of DITI testing is that it offers the oppurtunity of early detection of breast disease than has been possible through breast self examination or mammography alone.
Unlike most tests,DITI is:
* non invasive              * painless
* no radiation              * FDA approved
* endorsed by the United Breast Cancer Foundation
Current Early Detection Guidelines
One day there may be a single method for the early detection of breast cancer. Until then, using a combination of methods will increase your chances of detecting cancer in an early stage. These methods include:


  • Annual DITI screening for women of all ages
  • Mammography, when considered appropriate for women who aged 50 or older
  • Monthly breast self-examination
  • Personal awareness for changes in the breasts
  • Readiness to discuss quickly any such changes with a doctor the best possible evaluation of breast health is made.

These guidelines should be considered along with your background and medical history.

This test is designed to improve chances for detecting fast-growing, active tumors in the intervals between mammographic screenings or when mammography is not indicated by screening guidlines for women under 50 years of age.